Article Versions Notes

Duskey JT, Rinaldi A, Ottonelli I, Caraffi R, De Benedictis CA, Sauer AK, Tosi G, Vandelli MA, Ruozi B, Grabrucker AM. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics. 2022; 14(7):1450. https://doi.org/10.3390/pharmaceutics14071450

Duskey, Jason Thomas, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi, and Andreas Martin Grabrucker. 2022. "Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments" Pharmaceutics 14, no. 7: 1450. https://doi.org/10.3390/pharmaceutics14071450

Duskey, J. T., Rinaldi, A., Ottonelli, I., Caraffi, R., De Benedictis, C. A., Sauer, A. K., Tosi, G., Vandelli, M. A., Ruozi, B., & Grabrucker, A. M. (2022). Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics, 14(7), 1450. https://doi.org/10.3390/pharmaceutics14071450